Kanauchi et al., 2002 - Google Patents
Treatment of ulcerative colitis by feeding with germinated barley foodstuff: first report of a multicenter open control trialKanauchi et al., 2002
- Document ID
- 9652327368920600706
- Author
- Kanauchi O
- Suga T
- Tochihara M
- Hibi T
- Naganuma M
- Homma T
- Asakura H
- Nakano H
- Takahama K
- Fujiyama Y
- Andoh A
- Shimoyama T
- Hida N
- Haruma K
- Koga H
- Mitsuyama K
- Sata M
- Fukuda M
- Kojima A
- Bamba T
- Publication year
- Publication venue
- Journal of gastroenterology
External Links
Snippet
Background. Germinated barley foodstuff (GBF) is a prebiotic foodstuff that effectively increases luminal butyrate production by stimulating the growth of protective bacteria. In the first pilot study, GBF has been shown to reduce both clinical activity and mucosal …
- 206010009900 Colitis ulcerative 0 title abstract description 34
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
- A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
- A61K35/66—Micro-organisms or materials therefrom
- A61K35/74—Bacteria
- A61K35/741—Probiotics
- A61K35/744—Lactic acid bacteria, e.g. enterococci, pediococci, lactococci, streptococci or leuconostocs
- A61K35/747—Lactobacilli, e.g. L. acidophilus or L. brevis
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
- A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
- A61K35/66—Micro-organisms or materials therefrom
- A61K35/74—Bacteria
- A61K35/741—Probiotics
- A61K35/744—Lactic acid bacteria, e.g. enterococci, pediococci, lactococci, streptococci or leuconostocs
- A61K35/745—Bifidobacteria
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/47—Euphorbiaceae (Spurge family), e.g. Ricinus (castorbean)
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/70—Carbohydrates; Sugars; Derivatives thereof
- A61K31/715—Polysaccharides, i.e. having more than five saccharide radicals attached to each other by glycosidic linkages; Derivatives thereof, e.g. ethers, esters
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/06—Fungi, e.g. yeasts
- A61K36/062—Ascomycota
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
- A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
- A61K35/12—Materials from mammals; Compositions comprising non-specified tissues or cells; Compositions comprising non-embryonic stem cells; Genetically modified cells
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
- A61K45/00—Medicinal preparations containing active ingredients not provided for in groups A61K31/00 - A61K41/00
- A61K45/06—Mixtures of active ingredients without chemical characterisation, e.g. antiphlogistics and cardiaca
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
- A61K38/00—Medicinal preparations containing peptides
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| Kanauchi et al. | Treatment of ulcerative colitis by feeding with germinated barley foodstuff: first report of a multicenter open control trial | |
| Kanauchi et al. | The beneficial effects of microflora, especially obligate anaerobes, and their products on the colonic environment in inflammatory bowel disease | |
| JP6608047B2 (en) | Novel lactic acid bacteria having various functions and uses thereof | |
| Hanai et al. | Germinated barley foodstuff prolongs remission in patients with ulcerative colitis | |
| EP2124972B1 (en) | Use of a composition made of mineral nutrients and optionally acetogenic and/or butyrogenic bacteria in order to avoid or reduce the formation of gas in the large intestine of a mammal and the resulting abdominal problems | |
| Fukuda et al. | Prebiotic treatment of experimental colitis with germinated barley foodstuff: a comparison with probiotic or antibiotic treatment | |
| JP4455333B2 (en) | Probiotic bacteria: Lactobacillus fermentum | |
| DE69533593T2 (en) | PREPARATIONS FOR THE TREATMENT OF GASTROINTESTINAL DISORDER CONTAINING ARABINOGALACTAN AND POLYPHENOLS OF LARIX. | |
| JP2022000040A (en) | Use of pasteurized akkermansia for treating metabolic disorders | |
| CN103908585B (en) | For the probiotics fermention compositions of prevention and therapy constipation | |
| CN112672749B (en) | Novel bifidobacterium longum strain or lactobacillus rhamnosus strain having obesity preventing or treating effect and use thereof | |
| JP2018532779A (en) | Felicaribacterium prausnitzi and desulfobibriopigel for use in the treatment or prevention of diabetes and bowel disease | |
| CN109481473A (en) | Application of the bacteroides fragilis extract in the drug or food of preparation prevention and treatment irritable bowel syndrome | |
| KR102413408B1 (en) | Microbial carotenoids that affect gut microbiota composition | |
| EA021890B1 (en) | Method for prevention and/or treatment of inflammatory bowel disease, ulcerative colitis and crohn's disease | |
| Ren et al. | The probiotic Lactobacillus paracasei ameliorates diarrhea cause by Escherichia coli O8 via gut microbiota modulation1 | |
| WO2018103808A1 (en) | A fermented composition comprising a high content of one or more lactic acid bacterial strains and a method for making the composition and use thereof | |
| CN106721834A (en) | A kind of solid beverage for improving women's health problem | |
| Mitsuyama et al. | Intestinal microflora as a therapeutic target in inflammatory bowel disease | |
| CN101134051A (en) | Application of clostridium butyricum, condensate bacillus and bifidobacteria in the preparation of medicament for treating irritable bowel syndrome, cold diarrhoea and drink diarrhoea | |
| Uchida et al. | Milk whey culture with Propionibacterium freudenreichii ET-3 is effective on the colitis induced by 2, 4, 6-trinitrobenzene sulfonic acid in rats | |
| CN101076346B (en) | Lactic acid bacteria and its application in preventing diarrhea | |
| KR100526992B1 (en) | Fermented extract of a fruit of the trifoliate orange, and a composition for treating the disease caused by infection of helicobacter pylori | |
| WO2023236452A1 (en) | Probiotic patch for preventing and treating oral ulcer, method for preparing same and use thereof | |
| KR20230121689A (en) | Composition of synbiotics for improving Irritable Bowel Syndrome comprising Opuntia humifusa extract and lactobacillus |